Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Zigeuner

Showing results (111-120 of 166) with videos related to

Pageof 17
Sort By:
Clinical Genitourinary Cancer|April 21, 2022
Benefit of Metastasectomy in Renal Cell Carcinoma: A Propensity Score AnalysisFranziska Maisel, Maria A Smolle, Stefanie Mollnar, et al.
International Journal of Cancer|August 11, 2007
Patients with renal cell carcinoma nodal metastases can be accurately identified: external validation of a new nomogramGeorg C Hutterer, Jean-Jacques Patard, Paul Perrotte, et al.
European Urology|August 22, 2008
A preoperative prognostic model for patients treated with nephrectomy for renal cell carcinomaPierre I Karakiewicz, Nazareno Suardi, Umberto Capitanio, et al.
European Urology|February 24, 2007
Prognostic relevance of tumour size in T3a renal cell carcinoma: a multicentre experienceJohn S Lam, Tobias Klatte, Jean-Jacques Patard, et al.
Urology|October 11, 2008
Evidence-based sex-related outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: results of large multicenter studyMario I Fernández, Shahrokh F Shariat, Vitaly Margulis, et al.
Clinical Genitourinary Cancer|July 4, 2013
Prognostic effect of sarcomatoid dedifferentiation in patients with surgically treated renal cell carcinoma: a matched-pair analysisSabine Brookman-May, Matthias May, Shahrokh F Shariat, et al.
European Urology Focus|November 22, 2017
Potential Benefit of Lymph Node Dissection During Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the European Association of Urology Guidelines Panel on Non-muscle-invasive Bladder CancerJose Luis Dominguez-Escrig, Benoit Peyronnet, Thomas Seisen, et al.
European Urology|March 21, 2020
Transurethral Resection of Bladder Tumour: The Neglected Procedure in the Technology Race in Bladder CancerHugh Mostafid, Marko Babjuk, Bernard Bochner, et al.
Urologic Oncology|May 11, 2010
Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomyJeffery C Wheat, Alon Z Weizer, J Stuart Wolf, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|December 11, 2008
Age at diagnosis is a determinant factor of renal cell carcinoma-specific survival in patients treated with nephrectomyPierre I Karakiewicz, Claudio Jeldres, Nazareno Suardi, et al.
Pageof 17

Showing results (111-120 of 166) with videos related to

Sort By:
Pageof 17
Clinical Genitourinary Cancer|April 21, 2022
Benefit of Metastasectomy in Renal Cell Carcinoma: A Propensity Score AnalysisFranziska Maisel, Maria A Smolle, Stefanie Mollnar, et al.
International Journal of Cancer|August 11, 2007
Patients with renal cell carcinoma nodal metastases can be accurately identified: external validation of a new nomogramGeorg C Hutterer, Jean-Jacques Patard, Paul Perrotte, et al.
European Urology|August 22, 2008
A preoperative prognostic model for patients treated with nephrectomy for renal cell carcinomaPierre I Karakiewicz, Nazareno Suardi, Umberto Capitanio, et al.
European Urology|February 24, 2007
Prognostic relevance of tumour size in T3a renal cell carcinoma: a multicentre experienceJohn S Lam, Tobias Klatte, Jean-Jacques Patard, et al.
Urology|October 11, 2008
Evidence-based sex-related outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: results of large multicenter studyMario I Fernández, Shahrokh F Shariat, Vitaly Margulis, et al.
Clinical Genitourinary Cancer|July 4, 2013
Prognostic effect of sarcomatoid dedifferentiation in patients with surgically treated renal cell carcinoma: a matched-pair analysisSabine Brookman-May, Matthias May, Shahrokh F Shariat, et al.
European Urology Focus|November 22, 2017
Potential Benefit of Lymph Node Dissection During Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the European Association of Urology Guidelines Panel on Non-muscle-invasive Bladder CancerJose Luis Dominguez-Escrig, Benoit Peyronnet, Thomas Seisen, et al.
European Urology|March 21, 2020
Transurethral Resection of Bladder Tumour: The Neglected Procedure in the Technology Race in Bladder CancerHugh Mostafid, Marko Babjuk, Bernard Bochner, et al.
Urologic Oncology|May 11, 2010
Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomyJeffery C Wheat, Alon Z Weizer, J Stuart Wolf, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|December 11, 2008
Age at diagnosis is a determinant factor of renal cell carcinoma-specific survival in patients treated with nephrectomyPierre I Karakiewicz, Claudio Jeldres, Nazareno Suardi, et al.
Pageof 17